97 related articles for article (PubMed ID: 1647545)
1. [Clinical, serological and immunogenetic studies of systemic sclerosis: a French response to the paper of JP Maddison].
Meyer O
Rev Rhum Mal Osteoartic; 1991 May; 58(5):371-3. PubMed ID: 1647545
[No Abstract] [Full Text] [Related]
2. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
3. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to pneumococcal polysaccharide vaccine in systemic sclerosis.
Mercado U; Acosta H; Diaz-Molina R
J Rheumatol; 2009 Jul; 36(7):1549-50. PubMed ID: 19567636
[No Abstract] [Full Text] [Related]
5. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
6. Should we look for anti-RNA polymerase III antibodies in systemic sclerosis patients with anti-centromere or anti-topoisomerase I antibodies?
Benyamine A; Bertin D; Heim X; Granel B; Bardin N
Eur J Intern Med; 2017 Oct; 44():e42-e44. PubMed ID: 28781194
[No Abstract] [Full Text] [Related]
7. [Anticentromere antibodies and other antinuclear antibodies in progressive systemic sclerosis].
Rojas C; Silva MC; Pérez L; Ruiz F
Rev Med Chil; 1985 May; 113(5):409-14. PubMed ID: 3912881
[No Abstract] [Full Text] [Related]
8. [Nuclear antibodies as serologic markers in progressive systemic scleroderma].
Lakomek HJ; Guldner HH; Bautz FA; Goerz G; Kind P; Mensing H; Krüskemper HL
Hautarzt; 1987 Feb; 38(2):63-9. PubMed ID: 3106261
[TBL] [Abstract][Full Text] [Related]
9. Antitopoisomerase and anticentromere antibodies in the sclerodermatosus complex.
Kallenberg CG
Clin Rev Allergy; 1994; 12(3):221-35. PubMed ID: 7804956
[No Abstract] [Full Text] [Related]
10. Microchimerism in Japanese patients with systemic sclerosis.
Ichikawa N; Kotake S; Hakoda M; Kamatani N
Arthritis Rheum; 2001 May; 44(5):1226-8. PubMed ID: 11352259
[No Abstract] [Full Text] [Related]
11. [Coexistence of antitopoisomerase I and anticentromere antibodies in systemic sclerosis].
Garrido Rasco R; Castillo Palma MJ; García Hernández FJ; Sánchez Román J
Med Clin (Barc); 2010 Sep; 135(9):430-1. PubMed ID: 19767035
[No Abstract] [Full Text] [Related]
12. Chromosome studies in scleroderma with consideration of anticentromere antibody status and assessment of possible in vitro clastogenic activity.
Powell FC; Schroeter AL; Winkelmann RK; Dewald GW
Acta Derm Venereol; 1986; 66(5):414-8. PubMed ID: 2431579
[TBL] [Abstract][Full Text] [Related]
13. [Systemic sclerosis autoantibodies: what dermatologists must know].
Hüe S; Ingen-Housz-Oro S; Cosnes A
Ann Dermatol Venereol; 2013 Feb; 140(2):143-9. PubMed ID: 23395500
[No Abstract] [Full Text] [Related]
14. [Comparison of three methods for the detection of anti-SCL70 autoantibodies].
Yalaoui S; Gorgi Y; Ayed K
Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398
[No Abstract] [Full Text] [Related]
15. [What can be expected of biological tests in scleroderma?].
Meyer O
Ann Med Interne (Paris); 1984; 135(8):584-90. PubMed ID: 6335633
[TBL] [Abstract][Full Text] [Related]
16. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
17. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases.
Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S
J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966
[TBL] [Abstract][Full Text] [Related]
18. [Progress in clinical tests and the pathophysiological study of collagen diseases--anti-topoisomerase I antibodies and anticentromere antibodies].
Konndo H
Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2409-13. PubMed ID: 9922659
[No Abstract] [Full Text] [Related]
19. Coexistence of serum anti-DNA topoisomerase I and anti-Sm antibodies: report of 3 cases.
Kameda H; Kuwana M; Hama N; Kaburaki J; Homma M
J Rheumatol; 1997 Feb; 24(2):400-3. PubMed ID: 9035005
[TBL] [Abstract][Full Text] [Related]
20. [Antinuclear antibodies in progressive systemic sclerosis].
Sepúlveda C; Palma S; Guzmán L; Bravo M
Rev Med Chil; 1986 Aug; 114(8):731-6. PubMed ID: 3554436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
